TrialSignal
Clinical trial intelligence report
Artificial Saliva in Diabetes Type II: a Randomized Registry Cross Over Study
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT03452085-Jul 28, 2026
NCT ID
NCT03452085
Status
COMPLETED
Phase
NA
Sponsor
Certmedica International GmbH
Executive brief
Investment-Ready Snapshot
Artificial Saliva in Diabetes Type II: a Randomized Registry Cross Over Study is a NA clinical asset sponsored by Certmedica International GmbH in Xerostomia Due to Hyposecretion of Salivary Gland, Diabetes Mellitus, Type 2. SEO and diligence focus: artificial saliva spray (AS), maritime throat spray (TT), endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT03452085
Indication
Xerostomia Due to Hyposecretion of Salivary Gland
Modality
medical device
Target
artificial saliva spray (AS), maritime throat spray (TT)
Intervention
artificial saliva spray (AS), maritime throat spray (TT)
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.